BE464884A - - Google Patents
Info
- Publication number
- BE464884A BE464884A BE464884DA BE464884A BE 464884 A BE464884 A BE 464884A BE 464884D A BE464884D A BE 464884DA BE 464884 A BE464884 A BE 464884A
- Authority
- BE
- Belgium
- Prior art keywords
- gram
- bisulfite
- menadione
- molecules
- molecule
- Prior art date
Links
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 46
- 229940041603 vitamin k 3 Drugs 0.000 claims description 23
- 235000012711 vitamin K3 Nutrition 0.000 claims description 21
- 239000011652 vitamin K3 Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 10
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 8
- 230000002364 anti-haemorrhagic effect Effects 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 235000019168 vitamin K Nutrition 0.000 claims description 7
- 239000011712 vitamin K Substances 0.000 claims description 7
- 229930003448 Vitamin K Natural products 0.000 claims description 6
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 6
- 229940046010 vitamin k Drugs 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 239000011872 intimate mixture Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- SZMRMIJZRCGDOS-UHFFFAOYSA-N hydrogen sulfite;methylazanium Chemical compound NC.OS(O)=O SZMRMIJZRCGDOS-UHFFFAOYSA-N 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- RJXWIPIAEZVSOM-UHFFFAOYSA-N piperidine sulfurous acid Chemical compound S(O)(O)=O.N1CCCCC1 RJXWIPIAEZVSOM-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 235000019441 ethanol Nutrition 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000000203 mixture Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000003833 bile salt Substances 0.000 description 3
- 229940093761 bile salts Drugs 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 1
- 241000252254 Catostomidae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XAFGBGWOYGJMQK-UHFFFAOYSA-N N-butylbutan-1-amine sulfurous acid Chemical compound S(O)(O)=O.C(CCC)NCCCC XAFGBGWOYGJMQK-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- CSZWNFWYVAKOEC-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfurous acid Chemical compound CN(C)C.OS(O)=O CSZWNFWYVAKOEC-UHFFFAOYSA-N 0.000 description 1
- MRSYJIKDSVHIGE-UHFFFAOYSA-N n-ethylethanamine;sulfurous acid Chemical compound OS(O)=O.CCNCC MRSYJIKDSVHIGE-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE464884A true BE464884A (en:Method) |
Family
ID=116604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE464884D BE464884A (en:Method) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE464884A (en:Method) |
-
0
- BE BE464884D patent/BE464884A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0287488B1 (fr) | Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition | |
| CA2102777C (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
| RU2453323C2 (ru) | Композиции, содержащие экстракты cynara scolymus и phaseolus vulgaris, которые полезны для лечения ожирения | |
| JP3631782B2 (ja) | ウルソデオキシコール酸を含む液体投与形態の薬剤 | |
| CH638973A5 (fr) | Procede de preparation d'une composition pour traiter la cavite orale et composition obtenue. | |
| CN103830744B (zh) | 一种缓释型鞣花酸-环糊精复合物及其制备方法 | |
| CA2354574C (fr) | Troxerutine a forte teneur en trihydroxy-ethyl-rutoside et procede de preparation | |
| BE464884A (en:Method) | ||
| BE507692A (fr) | Perfectionnements apportés aux procedés de préparation de produits thérapeutiques | |
| JP3228534B2 (ja) | 血中アルコール濃度低下用組成物 | |
| FR2548537A1 (en:Method) | ||
| CH368151A (fr) | Procédé de fabrication d'agents antidiabétiques | |
| JP3995202B2 (ja) | 経口用ウコン類組成物 | |
| Moore et al. | On the functions of the bile as a solvent | |
| EP0746325B1 (fr) | Gelee laxative hypocalorique a base d'huile de paraffine liquide et de lactulose, son procede de preparation | |
| LU85812A1 (fr) | Forme dosee d'etoposide a usage oral | |
| CN114601161B (zh) | 一种高稳定性异-α-酸及其衍生物纳米微胶囊及其制备方法 | |
| EP0116182B1 (fr) | Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé | |
| FR2616068A1 (fr) | Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises | |
| BE1007926A3 (fr) | Composition pharmaceutique contenant de la n-acetyl-cysteine. | |
| BE523745A (en:Method) | ||
| CA2022447A1 (fr) | Forme galenique orale ameliorant la biodisponibilite | |
| BE483577A (en:Method) | ||
| CN118105345A (zh) | 一种用于儿童发热的右旋布洛芬滴剂组合物及其制备方法 | |
| CN115350120A (zh) | 婴儿用手口湿巾组合物和湿巾 |